Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Kidney and Bladder Cancers:
Document related concepts
no text concepts found
Transcript
CME Information 2017 Kidney and Bladder Cancers: This biennial, multidisciplinary, one-day conference will provide a clinical update on the biology, therapeutic modalities and medical management in patients with kidney and bladder (urothelial) cancers. Didactic lectures will present current science, ongoing clinical trials and future research directions including many recent advances in multi-disciplinary management approaches to patients with early stage, high risk, and metastatic disease. Interactive discussions with experts in the field will enhance the learning experience. Target Audience This conference is intended for urologists, medical oncologists, radiation oncologists, nurses, advanced practice clinicians, residents, fellows and healthcare practitioners interested in the biology and management of kidney and bladder cancers. MedStar Georgetown University Hospital designates this live activity for a maximum of 7 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Disclosure of Financial Relationships with any Commercial Interest As a provider accredited by the ACCME, it is the policy of MedStar Georgetown University Hospital to require that everyone who is in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest prior to the educational activity. The ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner. Any individual who refuses to disclose relevant financial relationships will be disqualified from participating in the CME activity. For an individual with no relevant financial relationship(s), the participants must be informed that no conflicts of interest or financial relationships exist. For more information and to register, please visit http://CME.MedStarHealth.org/KBC Bladder Cancer • Describe the evaluation and management of recurrent non-muscle invasive bladder cancer • Evaluate molecular advances in urothelial carcinoma that support personalized bladder cancer management strategies • Describe the evolution of immunotherapy in the treatment of advanced urothelial cancer • Utilize appropriate multidisciplinary adjuvant therapy approaches for muscle invasive bladder cancer • Analyze critical clinical questions in urothelial carcinoma that are being addressed by clinical research CME Designation 3007 Tilden Street, NW, Suite 3N Washington, DC 20008 MedStar Georgetown University Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 2017 Kidney Cancer • Discuss current status of adjuvant therapy for patients with high risk kidney cancer • Analyze treatment options for second line therapy for VEGFR TKI resistance kidney cancer • Evaluate the role of immune therapy alone and in combination for patients with kidney cancer • Evaluate the role of surgery in the management of patients with all stages of kidney cancer • Analyze current unresolved clinical management issues and clinical research opportunities Updates on Clinical Management CME Accreditation Kidney and Bladder Cancers: Learning Objectives Updates on Clinical Management March 18, 2017 Georgetown University Hotel and Conference Center Washington, DC Course Co-Directors: Michael B. Atkins, MD MedStar Georgetown University Hospital Georgetown Lombardi Comprehensive Cancer Center Georgetown University Medical Center Washington, DC Keith J. Kowalczyk, MD MedStar Georgetown University Hospital Georgetown University Medical Center Washington, DC George K. Philips, MBBS, MD, MPH MedStar Washington Hospital Center MedStar Georgetown University Hospital Georgetown Lombardi Comprehensive Cancer Center Georgetown University Medical Center Washington, DC Lambros Stamatakis, MD Washington Cancer Institute MedStar Washington Hospital Center Washington, DC Faculty Course Co-Directors Michael B. Atkins, MD Deputy Director Georgetown Lombardi Comprehensive Cancer Center William M. Scholl Professor and Vice Chair Department of Oncology Georgetown University Medical Center Staff Physician, Division of Hematology/Oncology MedStar Georgetown University Hospital Washington, DC George K. Philips, MBBS, MD, MPH Vice Chair, Department of Medicine Staff Physician, Division of Hematology/Oncology MedStar Washington Hospital Center MedStar Georgetown University Hospital Washington, DC Keith J. Kowalczyk, MD Staff Physician, Department of Urology MedStar Georgetown University Hospital Associate Professor, Urologic Oncology Department of Urology Georgetown University Medical Center Washington, DC Lambros Stamatakis, MD Director, Section of Urologic Oncology Washington Cancer Institute MedStar Washington Hospital Center Washington, DC Faculty Piyush K. Agarwal, MD Head of the Bladder Cancer Section, Urologic Oncology Branch National Cancer Institute National Institutes of Health Bethesda, MD Andrea B. Apolo, MD Chief, Bladder Cancer Section, Genitourinary Malignancies Branch National Cancer Institute National Institutes of Health Bethesda, MD Toni K. Choueiri, MD Director, Lank Center for Genitourinary Oncology Department of Medical Oncology Dana-Farber Cancer Institute The Jerome and Nancy Kohlberg Endowed Chair Harvard Medical School Boston, MA Agenda Deborah Citrin, MD Senior Investigator Head, Section of Translational Radiation Oncology Radiation Oncology Branch Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda, MD Nancy A. Dawson, MD Director, Genitourinary Medical Oncology Program Professor, Medicine and Oncology Georgetown Lombardi Comprehensive Cancer Center Georgetown University School of Medicine Staff Physician, Division of Hematology/Oncology MedStar Georgetown University Hospital Washington, DC Naomi B. Haas, MD Director, Prostate and Kidney Cancer Program Associate Professor Abramson Cancer Center University of Pennsylvania Health System Philadelphia, PA Fiorina Kyritsi, MD Fellow, Internal Medicine George Washington University Washington, DC Christopher A. Loffredo, PhD Professor, Department of Oncology Professor, Department of Biostatistics, Bioinformatics, and Biomathematics Lombardi Comprehensive Cancer Center Georgetown University Medical Center Washington, DC David F. McDermott, MD Leader, Kidney Cancer Program Dana-Farber Harvard Cancer Center Director, Biologic Therapy and Cutaneous Oncology Programs Beth Israel Deaconess Medical Center Associate Professor of Medicine Harvard Medical School Boston, MA George J. Netto, MD Professor and Chair, Department of Pathology The University of Alabama at Birmingham Birmingham, Alabama Elizabeth R. Plimack, MD, MS Chief, Division of Genitourinary Medical Oncology Director, Genitorurinary Clinical Research Associate Professor, Department of Hematology and Oncology Fox Chase Cancer Center, Temple Health Philadelphia, PA Registration 7:00 AM Registration & Continental Breakfast SESSION II: Kidney Cancer 7:30 AM Introduction George K. Philips, MBBS, MD, MPH 11:15 AM SESSION I: Bladder Cancer 7:40 AM 8:00 AM 8:30 AM Global Epidemiology of Bladder Cancer Christopher A. Loffredo, PhD; Fiorina Kyritsi, MD Case Studies and Debate on Intravesical Therapy Piyush K. Agarwal, MD; Lambros Stamatakis, MD Advances and Opportunities in Peri-operative Systemic Therapy Andrea B. Apolo, MD Toward a Personalized Bladder Cancer Management: Molecular Pathologic Advances in Urothelial Carcinoma Georges J. Netto, MD 9:30 AM Break 9:45 AM The Evolution of Immunotherapy in the Treatment of Advanced Urothelial Cancer: Updates and Future Directions Elizabeth R. Plimack, MD, MS 9:00 AM 10:15 AM Novel Applications of Radiation Medicine in Bladder Cancer Deborah Citrin, MD 10:45 AM Panel Discussion Moderator: George K. Philips, MBBS, MD, MPH Panelists: P. Agarwal, A. Apolo, C. Loffredo, G. Netto, E. Plimack, L. Stamatakis Current Role of Robotic Surgery for Renal Malignancies Keith J. Kowalczyk, MD Prognostic and Predictive Factors and Status of Cytoreductive Nephrectomy Toni K. Choueiri, MD 12:00 PM Lunch 1:00 PM KEYNOTE LECTURE: Update on Immunotherapy of RCC David F. McDermott, MD 11:35 AM 1:45 PM 2:10 PM 2:35 PM Update on Anti-VEGFR Therapy/ M-Tor Therapy Nancy A. Dawson, MD Current Status of and Controversies in Adjuvant/Neoadjuvant Rx Naomi B. Haas, MD Systemic Therapy: Making Sense of the Present/Predicting the Future Michael B. Atkins, MD Case Presentations and Panel Discussion Moderator: Michael B. Atkins, MD Panelists: T. Choueiri, N. Dawson, N. Haas, K. Kowalczyk, D. McDermott 2:55 PM Closing Remarks Michael B. Atkins, MD 4:00 PM Adjourn 3:50 PM Registration Fees Physician $150 Resident/Fellow $50 Advanced Practice Clinician $75 Nurse $75 Allied Health Professional $75 Online Registration Preferred Please visit our secure website at http://CME.MedStarHealth.org/KBC updated program and registration information. We are unable to accept registrations or cancellations by telephone. If you wish to pay your registration fee by check, please download and print a registration form and mail it to the address on the registration form with your check. All registrations will be confirmed by email only. Please use an email address that you check regularly. If you have questions regarding registration or do not receive an email confirmation of your registration within 1-2 business days, please contact us at [email protected] or 202-780-1655. Cancellation Policy Cancellations made in writing by Monday, January 30, 2017 will be subject to a 50% penalty. No refunds will be given after Monday, January 30, 2017. Cancellations will not be accepted by telephone. In the unlikely event that the course is canceled, MedStar Health will refund the registration fee, but is not responsible for any travel costs. Please call 202-780-1655 or email [email protected] if you any questions or need any additional information. Venue Georgetown University Hotel and Conference Center 3800 Reservoir Road, NW Washington, DC 20007 202-687-3200 Special Assistance MedStar Health wishes to ensure that no individual with a disability is excluded, denied services, segregated or otherwise treated differently from other individuals because of the absence of auxiliary aids or services identified in the Americans with Disabilities Act. Please contact 202-780-1655 to notify us of your needs.
